ImmunityBio
IBRX
IBRX
57 hedge funds and large institutions have $83.2M invested in ImmunityBio in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
2% less funds holding
Funds holding: 58 → 57 (-1)
27% less capital invested
Capital invested by funds: $113M → $83.2M (-$30.1M)
Holders
57
Holding in Top 10
1
Calls
$480K
Puts
$220K
Top Buyers
| 1 | +$680K | |
| 2 | +$602K | |
| 3 | +$546K | |
| 4 |
HK
Horizon Kinetics
New York
|
+$382K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$294K |
Top Sellers
| 1 | -$704K | |
| 2 | -$562K | |
| 3 | -$380K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$197K |
| 5 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$180K |